Palantir shares slip by 7% despite posting record revenue in third quarter
Richard W. Fisher, a director at Tenet Healthcare Corp (NYSE:THC), sold 2,500 shares of common stock on October 29, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a price of $208.43, for a total transaction value of $521,075.
Following the transaction, Fisher directly owns 8,792 shares of Tenet Healthcare Corp.
In other recent news, Tenet Healthcare reported its third-quarter 2025 earnings, surpassing both earnings per share (EPS) and revenue forecasts. The company achieved an EPS of $3.70, exceeding the expected $3.34, and reported revenue of $5.29 billion, which was above the forecast of $5.26 billion. Following these results, Raymond James raised its price target for Tenet Healthcare to $250 from $200, maintaining an Outperform rating. Cantor Fitzgerald also increased its price target to $245 from $190, citing a 6.5x EV/EBITDA multiple on their 2027 estimated EBITDA of approximately $4.9 billion. Additionally, Guggenheim raised its price target to $238 from $221, highlighting the company’s strong performance across its business segments and effective cost management. The firm noted favorable growth in Tenet’s United Surgical Partners International division. These developments reflect analysts’ positive outlook on Tenet Healthcare’s financial performance and strategic initiatives.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.